Proteome Sciences (LON:PRM) Trading Down 5.1% – Time to Sell?

Proteome Sciences plc (LON:PRM)’s stock price dropped 5.1% during mid-day trading on Friday . The stock traded as low as GBX 1.50 and last traded at GBX 1.67. Approximately 538,226 shares were traded during trading, an increase of 117% from the average daily volume of 248,370 shares. The stock had previously closed at GBX 1.76.

Proteome Sciences Trading Down 5.1%

The firm has a fifty day simple moving average of GBX 2.43 and a two-hundred day simple moving average of GBX 2.85. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The stock has a market cap of £4.93 million, a PE ratio of -1.48 and a beta of 0.07.

Proteome Sciences (LON:PRM) last issued its quarterly earnings results on Thursday, September 25th. The company reported GBX (0.73) EPS for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.